Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kelindi is a French digital health company that develops software tools for family health, with a focus on pregnancy, toddlers, parents, and preventive monitoring. The company operates through its consumer-facing app brand Malo, now associated with Heloa, which provides guidance, tracking, and care-navigation support for families. Rather than developing therapeutics, Kelindi appears to function as a HealthTech software company building digital infrastructure and decision-support tools for everyday family health management. Public sources describe it as founded in 2020 in the Lille area of France and led by founder Florian Le Goff. The business appears commercial-stage for digital health software, though not a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kelindi.